VanEck Associates’s Crescent Capital BDC CCAP Stock Holding History
Bought
Maintained
Sold
Other funds holding CCAP
TCDRS
FNF
SLF
AM
BI
AC
VanEck Associates's CCAP Position: Q1 2026 in Review
VanEck Associates increased its Crescent Capital BDC (CCAP) stake by 0.48% in Q1 2026, buying an estimated $10.4K and bringing the position to 159,430 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #998.
VanEck Associates first reported a position in CCAP in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.23M in Q4 2025. 85 funds tracked by Wall St. Rank hold CCAP as of Q1 2026.
- VanEck Associates held 159,430 shares of Crescent Capital BDC worth $1.94M as of Q1 2026.
- VanEck Associates bought 763 Crescent Capital BDC shares in Q1 2026, an estimated $10.4K.
- Crescent Capital BDC made up ﹤0.01% of VanEck Associates's portfolio in Q1 2026, its #998 holding.
- VanEck Associates first reported a position in Crescent Capital BDC in Q1 2024 and has held it in 9 quarters since.
- VanEck Associates's Crescent Capital BDC position peaked at $2.23M in Q4 2025.
- 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q1 2026.
Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.